This website contains information on diabetes, intractable diseases, cancer, pre-disease (me-byo), longevity, 5-ALA, Biozipcode™, biomarkers, medical tourism, global medical expansion, and related topics.

This information is provided to introduce research and development, joint research, business concepts, and public materials. It does not guarantee the efficacy or safety of any specific treatment, drug, supplement, test, or medical service.

The content on this website is not a substitute for diagnosis, treatment, prescriptions, or medical advice from a physician. For any decisions regarding diabetes or other diseases, treatment plans, medication use, supplement intake, or medical testing, please consult a physician or other qualified medical professional.

Introducing the potential of research and technology is different from providing them as actual medical practice. This website seeks to make that distinction as clear as possible.

This website may use expressions such as “diabetes cure” or “research aimed at developing a diabetes cure” when referring to research involving Biozipcode Inc.

This wording does not mean that diabetes can necessarily be cured at this time. It also does not refer to an approved treatment that is already generally available.

Diabetes-related research being advanced by Biozipcode Inc. is still at the research and development stage, including preclinical research, joint research, preparation for clinical studies, and consideration of commercialization. Before it can be implemented in society as a treatment for humans, safety, efficacy, dosing methods, target patients, clinical trials, ethical review, regulatory approval, and other factors must be verified step by step.

This website aims to communicate the potential of the research while clearly distinguishing what can be stated at present from what still needs to be verified.

Biozipcode™ is a cell-targeting technology intended to recognize specific cells or tissues and deliver drugs or diagnostic substances to the intended cells.

Information about Biozipcode™ on this website is provided to introduce the outline of research and development, joint research, possible applications, and commercialization concepts. Applications to diabetes, cancer, autoimmune diseases, diagnostics, drug delivery, and other areas are being considered, but this does not mean that all of them have already been put into practical use.

At present, this does not guarantee that Biozipcode™ can treat or diagnose any specific disease, be used safely, or be generally used in clinical practice.

Research and applications related to Biozipcode™ should be verified step by step through collaboration with universities, research institutions, medical institutions, pharmaceutical companies, regulatory authorities, and other parties.

This website may explain research, products, business activities, clinical research concepts, and the relationship between 5-ALA, pre-disease (me-byo), metabolism, and diabetes.

Depending on the country and intended use, 5-ALA may be positioned differently, such as a health food, supplement, pharmaceutical raw material, ingredient for clinical research, or medical-use substance. Even for the same ingredient, the required checks differ depending on the sales method, labeling, target users, and intended purpose.

The information on this website does not guarantee that 5-ALA will cure diabetes or any other disease. It also does not recommend the purchase or intake of 5-ALA products as a specific treatment.

People with pre-existing conditions, those taking medication, pregnant or breastfeeding individuals, and anyone under medical supervision should always consult a physician or specialist before using supplements or health foods containing 5-ALA.

This website may contain information on UAE and GCC expansion, Palau-related projects, medical tourism in other overseas regions, pre-disease (me-byo) health screening, treatment center concepts, longevity, monitoring services, and global medical collaboration.

Some of this content may still be under consideration, in preparation, or at the concept stage. The published content does not guarantee the start of medical service provision, opening of facilities, therapeutic effects, safety, acquisition of local licenses, or government approvals at this time.

When receiving medical services overseas, it is necessary to carefully confirm the local healthcare system, medical institution, physician qualifications, treatment details, costs, risks, insurance, travel requirements, language support, and whether follow-up care can continue after returning home.

Medical tourism and global medical expansion involve not only medical care but also travel, accommodation, interpretation, insurance, legal systems, personal information, payments, and ongoing follow-up. These activities must be handled carefully based on each country’s systems and the judgment of medical institutions.

Business plans, fundraising, investment, business partnerships, overseas entities, joint research, medical tourism, Web3, and token-related information posted on this website are intended to explain the overview and direction of each project.

This information does not constitute investment solicitation, financial product transactions, fundraising, profit guarantees, principal guarantees, dividend guarantees, or promises of future business success.

Business plans and future concepts may include outlooks, schedules, goals, and expectations as of the time they were prepared. Actual results may change depending on research progress, fundraising status, partnerships, laws and regulations, regulatory approvals, clinical trials, market conditions, and government policies in each country.

When considering investment or business partnerships, please always review the latest materials, contracts, registration information, financial information, and legal, tax, accounting, and financial regulatory matters, and consult professionals in each relevant field.

This website may contain information on GDT / Global Development Token, Auring Ltd., PWD / PWDT concepts, Web3, digital payments, KYC/AML, and medical service payments.

This information is intended to explain the purpose, background, concept, and possible use of Web3-related projects. It does not promise an increase in token price, exchange listings, liquidity, revenue, dividends, principal guarantees, or convertibility.

Holding GDT or any other token does not automatically create medical effects, treatment results, priority access to medical services, investment returns, or legal rights.

Regulations concerning tokens and digital assets differ by country and region. Anyone considering participation, purchase, holding, use, or transfer should confirm the laws, tax rules, financial regulations, and crypto-asset regulations of their country or place of residence.

Web3, GDT, overseas entity, and token-related information posted on this website is not intended for token sales or investment solicitation directed at residents of Japan.

Information for Japan is organized mainly around 5-ALA products, research support, public materials, and project introductions. Information on crypto-assets and tokens may be posted as an explanation of overseas concepts or public materials.

For decisions in Japan concerning medical matters, the Pharmaceuticals and Medical Devices Act, health food labeling, financial product transactions, crypto-assets, tax, and consumer protection, please always consult qualified professionals.

This website seeks to separate information intended for Japan from overseas business concepts as clearly as possible.

This website may include company information, university announcements, academic papers, patents, press releases, business plans, white papers, PDF materials, and links to external websites.

These materials may contain information as of the time of preparation, future concepts, research-and-development-stage content, or information before later changes. After publication, the content, URLs, organizational structure, business plans, regulatory environment, and research progress may change.

This website does not guarantee the accuracy, completeness, or currency of content on external websites. Please check the latest information from each official site, publisher, or relevant institution as needed.

Public materials and external links are provided as entry points for readers to confirm information. When making important decisions, please always review the latest primary sources and seek confirmation from qualified professionals.

Rights to company names, service names, technology names, project names, trademarks, logos, materials, images, text, figures, and tables posted on this website belong to their respective rights holders.

Biozipcode™ and other names may be trademarks or registered trademarks of the relevant rights holders.

The content of this website may not be reproduced, copied, modified, or used commercially without permission. When quoting or introducing the content, please clearly indicate the source and obtain prior confirmation as necessary.

Academic papers, university announcements, external websites, PDF materials, and other resources each have their own copyright holders, publishers, and sources. Please check the rights notices and terms of use for each material before using it.

This website strives to provide accurate information where possible, but it does not always guarantee the accuracy, completeness, or currency of the posted content.

Company information, positions, project details, research progress, partnership status, business plans, linked destinations, and material content may change over time.

Information related to medicine, investment, Web3, overseas entities, regulations, and clinical research is especially subject to changes in systems and circumstances. When making important decisions, please do not rely solely on this website; review the latest official materials, contracts, registration information, and confirmations from relevant professionals.

This website is intended to explain the potential of research and business activities in an accessible way. It does not cover every factor needed for decision-making.

If you have any questions about the content of this website, public materials, links, company information, or project information, please contact us through the inquiry page.

However, this website does not provide individual advice on medical decisions, investment decisions, legal matters, tax, accounting, or financial regulations.

As necessary, please consult physicians, attorneys, tax accountants, certified public accountants, and specialists in finance, pharmaceutical affairs, medical advertising, and crypto-asset regulations.

This website aims to present the possibilities of research and business in a constructive manner while organizing information on medicine, investment, tokens, and overseas expansion without misunderstanding. Speaking about possibilities and guaranteeing outcomes are two different things. We believe that making this distinction clear is essential to trustworthy communication.